Showing results (31-40 of 185) with videos related to
Sort By:
Pageof 19
Neurogastroenterology and Motility|January 23, 2019
Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysisBo Broberg, Jan L Madsen, Stefan Fuglsang, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2019
Rapid decline in 51Cr-ethylenediaminetetraacetic acid-measured renal function during the first weeks following liver transplantationMads Hornum, Luit Penninga, Andreas A Rostved, et al.Nephron|December 2, 2020
The Use of HbA1c, Glycated Albumin and Continuous Glucose Monitoring to Assess Glucose Control in the Chronic Kidney Disease Population Including DialysisTobias Bomholt, Therese Adrian, Kirsten Nørgaard, et al.Diabetes Care|June 7, 2025
The Association Between Hemoglobin A1c and Complications Among Individuals With Diabetes and Severe Chronic Kidney DiseaseDea H Kofod, Nicholas Carlson, Thomas P Almdal, et al.Frontiers in Cell and Developmental Biology|June 30, 2020
Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical PatientsEsben Iversen, Morten Baltzer Houlind, Thomas Kallemose, et al.Cardiovascular Diabetology|June 16, 2023
Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort studyDea Haagensen Kofod, Nicholas Carlson, Ellen Freese Ballegaard, et al.BMJ Open|April 30, 2013
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention studyThomas Idorn, Filip K Knop, Morten Jørgensen, et al.Blood Purification|September 28, 2021
The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing HemodialysisTobias Bomholt, Marianne Rix, Thomas Almdal, et al.Journal of General Internal Medicine|November 25, 2025
COVID-19 Vaccination and Kidney Disease : SARS-CoV-2 Vaccine Effect on Risk of Infection and Subsequent Outcomes in Patients with Chronic Kidney DiseaseNicholas Carlson, Felix Michalik, Thomas Gerds, et al.Diabetes Care|August 19, 2015
Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized TrialThomas Idorn, Filip K Knop, Morten B Jørgensen, et al.Pageof 19